These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26632699)

  • 21. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
    Yu JY; Hu F; Du W; Ma XL; Yuan K
    J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
    Anstee QM; Liu YL; Day CP; Reeves HL
    J Hepatol; 2015 Apr; 62(4):982-3. PubMed ID: 25559329
    [No Abstract]   [Full Text] [Related]  

  • 23. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
    Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
    Krawczyk M; Stokes CS; Romeo S; Lammert F
    J Hepatol; 2015 Apr; 62(4):980-1. PubMed ID: 25559327
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk.
    Shen YH; Chen S; Peng YF; Shi YH; Huang XW; Yang GH; Ding ZB; Yi Y; Zhou J; Qiu SJ; Fan J; Ren N
    Tumour Biol; 2014 May; 35(5):4007-15. PubMed ID: 24399650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.
    Brouwer WP; van der Meer AJ; Boonstra A; Pas SD; de Knegt RJ; de Man RA; Hansen BE; ten Kate FJ; Janssen HL
    Liver Int; 2015 Feb; 35(2):438-47. PubMed ID: 25284145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.
    Takeuchi Y; Ikeda F; Moritou Y; Hagihara H; Yasunaka T; Kuwaki K; Miyake Y; Ohnishi H; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Nouso K; Yamamoto K
    J Gastroenterol; 2013 Mar; 48(3):405-12. PubMed ID: 22869157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
    Ueyama M; Nishida N; Korenaga M; Korenaga K; Kumagai E; Yanai H; Adachi H; Katsuyama H; Moriyama S; Hamasaki H; Sako A; Sugiyama M; Aoki Y; Imamura M; Murata K; Masaki N; Kawaguchi T; Torimura T; Hyogo H; Aikata H; Ito K; Sumida Y; Kanazawa A; Watada H; Okamoto K; Honda K; Kon K; Kanto T; Mizokami M; Watanabe S
    J Gastroenterol; 2016 Apr; 51(4):370-9. PubMed ID: 26337813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
    Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
    Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Yang Z; Wu Q; Shi Y; Nie Y; Wu K; Fan D
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
    Valenti L; Rametta R; Ruscica M; Dongiovanni P; Steffani L; Motta BM; Canavesi E; Fracanzani AL; Mozzi E; Roviaro G; Magni P; Fargion S
    BMC Gastroenterol; 2012 Aug; 12():111. PubMed ID: 22898488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
    Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ATG16L1 gene variant rs2241880 (p.T300A) is associated with susceptibility to HCC in patients with cirrhosis.
    Reuken PA; Lutz P; Casper M; Al-Herwi E; Stengel S; Spengler U; Stallmach A; Lammert F; Nischalke HD; Bruns T
    Liver Int; 2019 Dec; 39(12):2360-2367. PubMed ID: 31484215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
    Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P
    J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
    Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
    [No Abstract]   [Full Text] [Related]  

  • 40. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.
    Burza MA; Pirazzi C; Maglio C; Sjöholm K; Mancina RM; Svensson PA; Jacobson P; Adiels M; Baroni MG; Borén J; Ginanni Corradini S; Montalcini T; Sjöström L; Carlsson LM; Romeo S
    Dig Liver Dis; 2012 Dec; 44(12):1037-41. PubMed ID: 22704398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.